General Information of the Compound
Compound ID
CP0575759
Compound Name
N-[[2-chloro-4-(methanesulfonamido)phenyl]methyl]-4-piperidin-1-ylbenzamide
    Show/Hide
Structure
Formula
C20H24ClN3O3S
Molecular Weight
421.95
Canonical SMILES
CS(=O)(=O)Nc1ccc(CNC(=O)c2ccc(cc2)N2CCCCC2)c(Cl)c1
    Show/Hide
InChI
InChI=1S/C20H24ClN3O3S/c1-28(26,27)23-17-8-5-16(19(21)13-17)14-22-20(25)15-6-9-18(10-7-15)24-11-3-2-4-12-24/h5-10,13,23H,2-4,11-12,14H2,1H3,(H,22,25)
    Show/Hide
InChIKey
WBBGFRCRZXKADB-UHFFFAOYSA-N
Physicochemical Property
logP
3.6318
Rotatable Bonds
6
Heavy Atom Count
28
Polar Areas
78.51
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166630293
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS